Tirzepatide KwikPen update: Practical guidance for clinicians

Description

In this Product Explainer, A/Prof Samantha Hocking, Endocrinologist, explains the key changes to the tirzepatide KwikPen device, including operational steps, dosing considerations and patient counselling, with practical guidance for supporting safe and effective use (7 mins).

A/Prof Samantha Hocking

expert

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

Date published: 16 June 2026